Hepatitis c kidneys safe for transplant? new trial tests antiviral protection
NCT ID NCT03809533
First seen Nov 06, 2025 · Last updated May 18, 2026 · Updated 21 times
Summary
This study tests whether kidneys from donors with hepatitis C (HCV) can be safely transplanted into patients who do not have HCV. After transplant, patients receive an antiviral drug (Epclusa) to prevent or treat any HCV infection. The goal is to expand the donor pool and reduce waiting times for kidney transplants.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KIDNEY TRANSPLANTATION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
UPMC
Pittsburgh, Pennsylvania, 15213, United States
Conditions
Explore the condition pages connected to this study.